1. Home
  2. PTPI
  3. PTPI News

Latest Petros Pharmaceuticals Inc. (PTPI) News on December 22, 2024

PTPI

ACCESSWIRE

3 days ago

Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”

PTPI

ACCESSWIRE

5 days ago

Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually

Petros Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
PTPI

Simply Wall St.

a month ago

Petros Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Petros Pharmaceuticals Amends President’s Employment Terms
PTPI

TipRanks

2 months ago

Petros Pharmaceuticals Amends President’s Employment Terms

Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
PTPI

ACCESSWIRE

3 months ago

Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)

Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PTPI

ACCESSWIRE

4 months ago

Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Petros Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations
PTPI

Simply Wall St.

4 months ago

Petros Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations

Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
PTPI

ACCESSWIRE

5 months ago

Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)

Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
PTPI

ACCESSWIRE

5 months ago

Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance

Start Proud Opens the Market
PTPI

CNW Group

6 months ago

Start Proud Opens the Market

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it
PTPI

Associated Press Finance

6 months ago

Will recreational pot go on sale soon in Ohio? Medical marijuana stores can now apply to sell it

PTPI

Business Wire

6 months ago

Form 8.3 - Darktrace plc

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives
PTPI

Investor's Business Daily

6 months ago

Dow Jones Trims Losses As Yields Spike On Jobs Data; GameStop Dives

May jobs reports signals Fed's soft landing: US Labor Secretary
PTPI

Yahoo Finance Video

6 months ago

May jobs reports signals Fed's soft landing: US Labor Secretary

Notification of major holding in Kindred Group plc
PTPI

PR Newswire

6 months ago

Notification of major holding in Kindred Group plc

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024
PTPI

Business Wire

6 months ago

NICE to Webcast Financial Analyst and Investor Day at Interactions 2024

PTPI

Business Wire

6 months ago

Form 8.3 - DS Smith plc

Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch
PTPI

ACCESSWIRE

7 months ago

Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch

Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
PTPI

ACCESSWIRE

7 months ago

Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA

Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe
PTPI

ACCESSWIRE

7 months ago

Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe

Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
PTPI

GlobeNewswire

7 months ago

Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals

Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
PTPI

News Direct

8 months ago

Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health

Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health
PTPI

ACCESSWIRE

8 months ago

Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health

Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
PTPI

ACCESSWIRE

8 months ago

Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)

Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status
PTPI

ACCESSWIRE

9 months ago

Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status

Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider
PTPI

ACCESSWIRE

9 months ago

Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider

Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider
PTPI

ACCESSWIRE

10 months ago

Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider

Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
PTPI

PR Newswire

a year ago

Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023

Intellicheck Achieves ISO/IEC 27001:2013 and ISO/IEC 27001:2019 Recertification
PTPI

Business Wire

a year ago

Intellicheck Achieves ISO/IEC 27001:2013 and ISO/IEC 27001:2019 Recertification

Star Equity Holdings Announces $5.9 Million Sale-Leaseback Transaction
PTPI

GlobeNewswire

a year ago

Star Equity Holdings Announces $5.9 Million Sale-Leaseback Transaction

Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switch
PTPI

ACCESSWIRE

a year ago

Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA(R) (avanafil) Rx-to-OTC Switch

US$ 2 Billion Financing Agreement Executed, NextPlay Technologies, Inc.
PTPI

NewMediaWire

a year ago

US$ 2 Billion Financing Agreement Executed, NextPlay Technologies, Inc.

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
PTPI

PR Newswire

a year ago

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

GDC’s Exploring the Evolution of AI Influencers: From TikTok Storytelling to Instagram Allure
PTPI

GlobeNewswire

a year ago

GDC’s Exploring the Evolution of AI Influencers: From TikTok Storytelling to Instagram Allure

SEALSQ Unveils AIoT Strategy with WISeAI.IO at Davos AI Roundtable
PTPI

GlobeNewswire

a year ago

SEALSQ Unveils AIoT Strategy with WISeAI.IO at Davos AI Roundtable

Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch
PTPI

ACCESSWIRE

a year ago

Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA (avanafil) Rx-to-OTC Switch

OMH: Takeaways From Simply Sakal Acquisition
PTPI

Zacks Small Cap Research

a year ago

OMH: Takeaways From Simply Sakal Acquisition

Educational Development Corporation Announces Executed Fourth Amendment to Credit Agreement
PTPI

Newsfile

a year ago

Educational Development Corporation Announces Executed Fourth Amendment to Credit Agreement

SRM Launches New Retail Website for SipWithMe Brand
PTPI

GlobeNewswire

a year ago

SRM Launches New Retail Website for SipWithMe Brand

LiveOne (Nasdaq: LVO) Issues Fiscal 2025 Revenue Guidance of $140 - $155M with $16 - $20M of Adjusted EBITDA*
PTPI

GlobeNewswire

a year ago

LiveOne (Nasdaq: LVO) Issues Fiscal 2025 Revenue Guidance of $140 - $155M with $16 - $20M of Adjusted EBITDA*

Petros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA(R) (avanafil) the First Erectile Dysfunction Medication to Achieve OTC Status
PTPI

ACCESSWIRE

a year ago

Petros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA(R) (avanafil) the First Erectile Dysfunction Medication to Achieve OTC Status

Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Provider
PTPI

ACCESSWIRE

a year ago

Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Provider

NextPlay Technologies Receives Notice from Nasdaq
PTPI

GlobeNewswire

a year ago

NextPlay Technologies Receives Notice from Nasdaq

Mobilicom and Royalty Management Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
PTPI

ACCESSWIRE

a year ago

Mobilicom and Royalty Management Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Farmmi Ships High-Volume Repeat Order to Chile; Company Sees Golden Age for Mushrooms
PTPI

PR Newswire

a year ago

Farmmi Ships High-Volume Repeat Order to Chile; Company Sees Golden Age for Mushrooms

PTPI

Business Wire

a year ago

Fathom Digital Manufacturing Corporation Receives Non-Binding Acquisition Proposal From CORE Industrial Partners

Cineverse Inks Global Commercial YouTube Channel Agreement with Little Dot Studios
PTPI

PR Newswire

a year ago

Cineverse Inks Global Commercial YouTube Channel Agreement with Little Dot Studios

GD Culture Group’s Portfolio Company DigiTrax Releases its Patented AI Music Production Tool KR38R PRO
PTPI

GlobeNewswire

a year ago

GD Culture Group’s Portfolio Company DigiTrax Releases its Patented AI Music Production Tool KR38R PRO

MSSP Alert Names CISO Global to 2023 Top 250 Managed Security Services Providers List
PTPI

GlobeNewswire

a year ago

MSSP Alert Names CISO Global to 2023 Top 250 Managed Security Services Providers List

Upexi Revenue Increases 144% Year-Over-Year and 53.5% Sequentially to $27.3 Million for Fiscal First Quarter 2024
PTPI

ACCESSWIRE

a year ago

Upexi Revenue Increases 144% Year-Over-Year and 53.5% Sequentially to $27.3 Million for Fiscal First Quarter 2024

Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
PTPI

Simply Wall St.

a year ago

Hall of Fame Resort & Entertainment Company (NASDAQ:HOFV) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Homology enters reverse merger with Q32 Bio
PTPI

BioPharma Dive

a year ago

Homology enters reverse merger with Q32 Bio

PTPI

Business Wire

a year ago

Fathom Digital Manufacturing Reports Third Quarter 2023 Financial Results

Wheeler Real Estate Investment Trust, Inc. Announces the Release of Its Third Quarter 2023 Financial and Operating Results
PTPI

ACCESSWIRE

a year ago

Wheeler Real Estate Investment Trust, Inc. Announces the Release of Its Third Quarter 2023 Financial and Operating Results

Stran & Company, Inc.'s (NASDAQ:SWAG) Low P/S No Reason For Excitement
PTPI

Simply Wall St.

a year ago

Stran & Company, Inc.'s (NASDAQ:SWAG) Low P/S No Reason For Excitement

PTPI

PR Newswire

a year ago

VirnetX to Webcast Fireside Chat with CEO Kendall Larsen

OKYO Pharma Announces $5.84 Million Cash Raise and Payables Reduction
PTPI

GlobeNewswire

a year ago

OKYO Pharma Announces $5.84 Million Cash Raise and Payables Reduction

Share on Social Networks: